Free Trial

Omada Health (NASDAQ:OMDA) Coverage Initiated by Analysts at Morgan Stanley

Omada Health logo with Medical background

Research analysts at Morgan Stanley assumed coverage on shares of Omada Health (NASDAQ:OMDA - Get Free Report) in a note issued to investors on Tuesday, MarketBeat.com reports. The brokerage set an "overweight" rating and a $25.00 price target on the stock. Morgan Stanley's price objective suggests a potential upside of 34.19% from the company's current price.

A number of other research analysts also recently weighed in on the stock. Barclays started coverage on shares of Omada Health in a report on Tuesday. They set an "overweight" rating and a $21.00 price target on the stock. Canaccord Genuity Group started coverage on Omada Health in a report on Tuesday. They set a "buy" rating and a $27.00 target price on the stock. The Goldman Sachs Group initiated coverage on Omada Health in a research report on Tuesday. They issued a "buy" rating and a $29.00 price target for the company. Needham & Company LLC started coverage on Omada Health in a research note on Tuesday. They set a "buy" rating and a $23.00 price target for the company. Finally, JPMorgan Chase & Co. began coverage on Omada Health in a research note on Tuesday. They issued an "overweight" rating and a $19.00 price objective on the stock. One investment analyst has rated the stock with a hold rating and seven have issued a buy rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $23.57.

Get Our Latest Report on Omada Health

Omada Health Stock Performance

NASDAQ:OMDA traded up $0.53 during mid-day trading on Tuesday, reaching $18.63. The stock had a trading volume of 344,526 shares, compared to its average volume of 1,585,299. Omada Health has a fifty-two week low of $14.14 and a fifty-two week high of $28.40.

About Omada Health

(Get Free Report)

Omada's mission is to bend the curve. Our hope is that, one day, tomorrow's epidemiologists will notice a bend in disease curves, wonder what might be happening, and conclude that part of that impact has been Omada. As part of that mission, we strive to inspire and enable people to make lasting health changes on their own terms.

Read More

Analyst Recommendations for Omada Health (NASDAQ:OMDA)

Should You Invest $1,000 in Omada Health Right Now?

Before you consider Omada Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omada Health wasn't on the list.

While Omada Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

AI Stocks Are Printing Money — These 3 Are Just Getting Started
Why Drone Stocks Are Skyrocketing Right Now!
Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines